Weekly Roundup: May 1–7, 2020


More from:

This roundup contains a collection of the posts published on the Forum during the week of May 1–7, 2020.


A New Era For Activist Defense: Going Beyond the Relics of the 80s



Institutional Investors Signal: A Mix of Tougher Standards and Heightened Flexibility for the 2020 Proxy Season


Anticipated Securities Litigation in Response to the Pandemic


COVID-19 and Capital Allocation


Blood in the Water: COVID-19 M&A Implications


The Corporation as a Nexus for Regulation


The Pandemic is the Litmus Test of Stakeholderism


New or Updated Non-GAAP Financial Measure for COVID-19



Chairman Clayton’s Remarks to the Special Meeting of the Investor Advisory Committee


Considerations on Non-Employee Director Compensation


The Return of Poison Pills: A First Look at “Crisis Pills”


Board Members Preparedness for Major Risk Event Like COVID-19


Taking the Lead in Adopting Political Transparency in the COVID-19 Crisis


Asian Americans in the Boardroom


Reconsidering Activism in France


More from:
Trackbacks are closed, but you can post a comment.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  • Subscribe or Follow

  • Supported By:

  • Program on Corporate Governance Advisory Board

  • Programs Faculty & Senior Fellows